Zhiquan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhiquan Wang has a total of 284 co-authors. Here are the top co-authors by number of shared publications:
- Anne J. Novak
Division of Hematology Mayo Clinic Rochester Rochester Minnesota USA
15 shared publications - Brianna J. Negaard
Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
15 shared publications - Bruno Tesson
10Institut Carnot CALYM, Pierre-Bénite, France
15 shared publications - Emmanuel Contreras Guzman
Morgridge Institute for Research
15 shared publications - Franck Morschhauser
11Department of Hematology, Claude Huriez Hospital, Lille University Hospital, Lille, France
15 shared publications - Geoffrey Michael Nelson
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, USA
15 shared publications
Latest Publications
- Open Access
- 20 March 2026
- Published by Springer Nature in Leukemia
- Vol. 40 (6) , 1314-1317
Defining the acute BTK-loss transcriptional program in CLL using a BTK degrader
- 20 March 2026
- Published by Springer Nature in Leukemia
- Vol. 40 (6) , 1314-1317
Open AccessDefining the acute BTK-loss transcriptional program in CLL using a BTK degrader
- Open Access
- 27 November 2025
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 33 (5) , 1050-1064
Proximal proteomics analysis reveals DNA polymerase δ subunit 3 is a new MCM2 binding partner and promotes parental histones inheritance in mammalian cells
In mammalian cells, MCM2 and POLE3/4 safeguard the symmetrical segregation of parental histones to the leading and lagging strands of newly synthesized DNA. However, the identity of additional proteins involved in parental histone distribution remains elusive. We used TurboID proximity labeling to identify interaction partners of MCM2 and POLE3/4 in mouse cells. This approach provided a candidate protein library potentially involved in the MCM2 and POLE3/POLE4-mediated process of parental histone segregation. DNA polymerase δ subunit 3 (POLD3) was a protein whose intensity differed between the interactomes of wild-type MCM2 and its histone-binding mutant. We showed POLD3 bound to both MCM2 and the histone (H3-H4) 2 tetramers. Moreover, MCM2’s histone binding affected interactions between POLD3 and histone H3. More importantly, POLD3 was required for the symmetrical transfer of parental histones H3-H4 to the leading and lagging strands of newly synthesized DNA in mouse cells. In short, our findings establish that POLD3 forms a protein complex with MCM2 and histone (H3-H4) 2 tetramers, functioning as a novel histone chaperone to regulate parental histone segregation in mammalian cells.
- 27 November 2025
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 33 (5) , 1050-1064
Open AccessProximal proteomics analysis reveals DNA polymerase δ subunit 3 is a new MCM2 binding partner and promotes parental histones inheritance in mammalian cells
In mammalian cells, MCM2 and POLE3/4 safeguard the symmetrical segregation of parental histones to the leading and lagging strands of newly synthesized DNA. However, the identity of additional proteins involved in parental histone distribution remains elusive. We used TurboID proximity labeling to identify interaction partners of MCM2 and POLE3/4 in mouse cells. This approach provided a candidate protein library potentially involved in the MCM2 and POLE3/POLE4-mediated process of parental histone segregation. DNA polymerase δ subunit 3 (POLD3) was a protein whose intensity differed between the interactomes of wild-type MCM2 and its histone-binding mutant. We showed POLD3 bound to both MCM2 and the histone (H3-H4) 2 tetramers. Moreover, MCM2’s histone binding affected interactions between POLD3 and histone H3. More importantly, POLD3 was required for the symmetrical transfer of parental histones H3-H4 to the leading and lagging strands of newly synthesized DNA in mouse cells. In short, our findings establish that POLD3 forms a protein complex with MCM2 and histone (H3-H4) 2 tetramers, functioning as a novel histone chaperone to regulate parental histone segregation in mammalian cells.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Data from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Twenty percent of patients with follicular lymphoma relapse early with poor outcomes; however, the molecular mechanisms underlying this aggressive behavior are unknown. Using a multiomic approach, we show that patients with follicular lymphoma with elevated IRF4 expression (IRF4hi) have increased transformation risk, dysregulated immune signaling, and a suppressive tumor microenvironment. Loss- and gain-of-function experiments in IRF4hi lymphoma cells, along with chromatin profiling, demonstrate that IRF4 impairs their interaction with T cells by repressing antigen presentation and co-receptor gene modules while promoting the expression of cytokines that antagonize T-follicular helper cell and regulatory T-cell functions. Additionally, IRF4 rewires tumor metabolism and restricts glucose availability to immune cells. Silencing of IRF4 inhibits tumor cell growth and restores immune surveillance mechanisms, thus representing a promising target for therapy. Our data suggest that IRF4hi lymphoma cells co-opt a developmental mechanism used to exit the germinal center response in promoting a more aggressive cancer via engagement of multiple immune-evasive mechanisms.Significance:We show that IRF4 controls immune and metabolic signaling with functional effects on the cross-talk between B and T cells, resulting in a suppressive immune microenvironment when IRF4 is overexpressed in lymphoma. This underscores the importance of IRF4 as a pivotal therapeutic target to restore antitumor immunosurveillance for IRF4-associated lymphomas.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Twenty percent of patients with follicular lymphoma relapse early with poor outcomes; however, the molecular mechanisms underlying this aggressive behavior are unknown. Using a multiomic approach, we show that patients with follicular lymphoma with elevated IRF4 expression (IRF4hi) have increased transformation risk, dysregulated immune signaling, and a suppressive tumor microenvironment. Loss- and gain-of-function experiments in IRF4hi lymphoma cells, along with chromatin profiling, demonstrate that IRF4 impairs their interaction with T cells by repressing antigen presentation and co-receptor gene modules while promoting the expression of cytokines that antagonize T-follicular helper cell and regulatory T-cell functions. Additionally, IRF4 rewires tumor metabolism and restricts glucose availability to immune cells. Silencing of IRF4 inhibits tumor cell growth and restores immune surveillance mechanisms, thus representing a promising target for therapy. Our data suggest that IRF4hi lymphoma cells co-opt a developmental mechanism used to exit the germinal center response in promoting a more aggressive cancer via engagement of multiple immune-evasive mechanisms.Significance:We show that IRF4 controls immune and metabolic signaling with functional effects on the cross-talk between B and T cells, resulting in a suppressive immune microenvironment when IRF4 is overexpressed in lymphoma. This underscores the importance of IRF4 as a pivotal therapeutic target to restore antitumor immunosurveillance for IRF4-associated lymphomas.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
IRF4 rewires tumor metabolism with functional implications for the immune microenvironment.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
IRF4 rewires tumor metabolism with functional implications for the immune microenvironment.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
List of the antibodies used for the CyTOF experiment.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S6 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
List of the antibodies used for the CyTOF experiment.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Silencing of IRF4 enhances anti-lymphoma immune response.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Silencing of IRF4 enhances anti-lymphoma immune response.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Single cell analysis reveals an extensive immune exhaustion in FL with increased IRF4 expression.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Single cell analysis reveals an extensive immune exhaustion in FL with increased IRF4 expression.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3. from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Patient characteristics PRIMA cohort.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3. from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Patient characteristics PRIMA cohort.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Increased expression of IRF4 in FL biases B cells towards immature cell fate.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Increased expression of IRF4 in FL biases B cells towards immature cell fate.
- Open Access
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4. from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Probability of Event at 5 years in the MER and PRIMA cohorts.
- 3 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4. from IRF4 Promotes Immune Evasion and Shapes the Tumor Microenvironment in Follicular Lymphoma
Probability of Event at 5 years in the MER and PRIMA cohorts.